Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 57.70M | 53.82M | 55.07M | 36.18M | 14.59M | 9.54M |
Gross Profit | 7.37M | 12.23M | 23.08M | 14.60M | 6.72M | 5.01M |
EBITDA | -7.24M | -5.21M | 11.73M | 5.54M | 1.33M | 988.92K |
Net Income | -9.73M | -6.34M | 8.52M | 4.06M | 911.00K | 432.67K |
Balance Sheet | ||||||
Total Assets | 47.42M | 47.42M | 48.36M | 28.20M | 11.62M | 6.57M |
Cash, Cash Equivalents and Short-Term Investments | 6.36M | 6.36M | 3.22M | 4.07M | 4.28M | 3.62M |
Total Debt | 6.70M | 6.70M | 7.93M | 191.00K | 5.18M | 2.16M |
Total Liabilities | 28.45M | 28.45M | 23.35M | 11.76M | 9.35M | 5.26M |
Stockholders Equity | 18.96M | 18.96M | 25.02M | 16.44M | 2.28M | 1.31M |
Cash Flow | ||||||
Free Cash Flow | 892.00K | 5.00M | -4.20M | 392.00K | -1.76M | 1.39M |
Operating Cash Flow | 1.88M | 6.39M | -3.04M | 3.66M | 4.74K | 1.43M |
Investing Cash Flow | -1.39M | -1.77M | -2.77M | -8.38M | -1.76M | -40.91K |
Financing Cash Flow | -1.79M | -2.02M | 4.97M | 4.50M | 2.43M | 1.26M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
67 Neutral | $16.52B | 16.88 | 4.47% | 3.58% | 4.76% | 6.17% | |
65 Neutral | £33.06M | 7.64 | 2.59% | ― | 70.15% | -59.70% | |
56 Neutral | £121.15M | ― | -45.83% | ― | -77.21% | 49.54% | |
48 Neutral | £16.99M | 0.62 | -60.63% | ― | -5.94% | -179.20% | |
45 Neutral | £6.31M | ― | -47.98% | ― | 1.44% | -251.55% | |
― | €93.93M | ― | -27.33% | ― | ― | ― | |
― | £27.26M | ― | -199.63% | ― | ― | ― |